BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5458636)

  • 1. [Role of cellular structures of cholera and non-cholera vibrios in the development of non-specific resistance].
    Zykin LF; Petrova LS
    Antibiotiki; 1970 Jun; 15(6):537-40. PubMed ID: 5458636
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of antigenic structure of streptomycin resistant strains of El'-Tor vibrios by the method of diffuse precipitation in gel].
    Gnetnev AM
    Antibiotiki; 1969 Apr; 14(4):336-41. PubMed ID: 4977640
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies on the protective value of different antigenic preparations from cholera vibrios.
    Sanyal SC; Narayanaswami A; Mukerjee S
    Indian J Med Res; 1969 Sep; 57(9):1621-8. PubMed ID: 5369787
    [No Abstract]   [Full Text] [Related]  

  • 4. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative characteristics of the polysaccharide-containing complexes of whole cells and cellular walls of the parachloreric vibrions].
    Efremova VI; Ermol'eva ZV; Efimtseva EP
    Mikrobiol Zh; 1971; 33(1):7-12. PubMed ID: 5559347
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isolation and various properties of the cellular components of the cholera vibrion. I. Extraction of the cellular structures and a study of the antigenic properties of the Ogawa type vibrion].
    Zykin LF
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Dec; 45(12):38-43. PubMed ID: 4979814
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenic studies on non-agglutinable vibrios with particular reference to toxigenicity.
    Ghosh AK; De SP; Mukerjee S
    Ann Inst Pasteur (Paris); 1970 Jan; 118(1):41-8. PubMed ID: 4984607
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical composition of some cellular structures of Vibrio cholerae.
    Yefimtseva EP; Yermolyeva ZV; Zykin LF; Gurevitch EI
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):398-403. PubMed ID: 4674090
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell wall antigens in Vibrio cholerae O139 Bengal, a causative agent of new epidemics.
    Weintraub A; Jansson PE; Jansson M; Paredes L; Hultenby K; Widmalm G; Albert MJ
    Prog Clin Biol Res; 1995; 392():141-50. PubMed ID: 8524919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of exotoxins and endotoxins of cholera-like vibrions using the immunoelectrophoretic method and gel precipitation reaction].
    Vvedenskaia OI; Givental' NI; Ermol'eva ZV
    Antibiotiki; 1972 Jul; 17(7):602-7. PubMed ID: 4655010
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on the Texas Star-SR avirulent A-B+ mutant candidate cholera vaccine.
    Finkelstein RA; Boesman-Finkelstein M
    Dev Biol Stand; 1983; 53():89-92. PubMed ID: 6873480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative differences in antitoxic and antibacterial immunogenesis after live and killed enteral cholera vaccination.
    Bhattacharya P; Mukerjee S
    Indian J Med Res; 1970 Nov; 58(11):1569-77. PubMed ID: 5505346
    [No Abstract]   [Full Text] [Related]  

  • 14. [The problem of binding of capsule antigens to the component parts of the bacterial cell wall].
    Nimmich W
    Acta Biol Med Ger; 1969; 22(1):191-5. PubMed ID: 5363899
    [No Abstract]   [Full Text] [Related]  

  • 15. An experimental study of non-agglutinable vibrios which caused gastroenteritis in clinical cases.
    Kumar S; Dutta NK
    Indian J Med Res; 1971 Sep; 59(9):1378-84. PubMed ID: 5161564
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative assay of a protein antigen of vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    Aust J Exp Biol Med Sci; 1971 Dec; 49(6):605-12. PubMed ID: 5170447
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera vaccines.
    Sinha R
    J Indian Med Assoc; 1971 Nov; 57(10):390-2. PubMed ID: 5140827
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.